drugset / Trial / NCT00539526

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

NCT00539526

Phase 4 Completed 106 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will evaluate hyperemia and ocular surface tolerability in patients on prostaglandin analogues

Timeline

Start
2007-09
Primary completion
2008-07
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 % Other
Comparator Latanoprost Small molecule 0.005 % Other
Comparator Travoprost Other / unclassified 0.004 % Other